Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 7938014.
- Also identified by PMC identifier 45090.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The low-affinity nerve growth factor receptor (NGFR) p75NGFR induces apoptosis in the absence of nerve growth factor (NGF) binding but enhances neural survival when bound by NGF. Basal forebrain cholinergic neurons express the highest levels of p75NGFR in the adult human brain and are preferentially involved in Alzheimer disease, raising the question of whether there may be a functional relationship between the expression of p75NGFR and basal forebrain cholinergic neuronal degeneration in Alzheimer disease. The expression of p75NGFR by wild-type and mutant PC12 cells potentiated cell death induced by beta-amyloid peptide. NGF binding to p75NGFR inhibited the toxicity of beta-amyloid peptide, whereas NGF binding to TrkA, the high-affinity NGFR, enhanced it. These results suggest a possible link between beta-amyloid peptide toxicity and preferential degeneration of cells expressing p75NGFR.
Medical subject headings
- Amyloid beta-Peptides
- Nerve Growth Factors
- Neurotoxins
- Proto-Oncogene Proteins
- Receptor Protein-Tyrosine Kinases
- Receptors, Nerve Growth Factor